According to a filing with the Securities and Exchange Commission (SEC) dated February 17, 2026, Socorro Asset Management LP lost its entire stake. Alexandria Real Estate Equipment (NYSE:ARE)sold 62,346 shares.
-
Socorro sold out of ARE, reducing its position from 1.9% of AUM to zero last quarter.
-
Holding High Stocks After Filing:
-
NYSE:SRE: $11.82 million (4.7% of AUM)
-
NYSE:MS: $11.23 million (4.5% of AUM)
-
NYSE:PNC: $11.08 million (4.4% of AUM)
-
NYSE:KO: $9.85 million (3.9% of AUM)
-
-
As of February 18, 2026, ARE’s share price was at $54.16, down 39.8% from the previous year, underperforming the S&P 500 by 52.1 percentage points.
|
Matric |
value |
|---|---|
|
Revenue (TTM) |
3.03 billion dollars |
|
net income (TTM) |
($1.23 billion) |
|
Dividend yield |
8.66% |
|
Price (as of market close February 27, 2026) |
$54.04 |
-
Owns, operates, and develops co-living science, technology, and agtech campuses, generating revenue primarily from leasing Class A office and laboratory space in major innovation clusters.
-
Operates as a real estate investment trust (REIT), earning income through long-term leases and strategic equity investments in rental companies
-
Serving biotechnology, pharmaceutical, technology, and agricultural technology companies seeking high-quality, innovation-focused workplaces in key U.S. cities.
Alexandria Real Estate Equities, Inc. is a leading S&P 500 REIT specializing in urban office and laboratory campuses for the life sciences and technology sectors. The company leverages a unique asset base clustered in the United States’ top innovation markets to attract a diverse, high-quality tenant roster. A focus on Class A properties and strategic investments provides a differentiated platform for long-term value creation in the innovative real estate sector.
Socorro’s exposure to Alexandria real estate was relatively low before it closed its position entirely in the fourth quarter. At the end of September, it was the company’s 32nd largest holding out of a total of 33 holdings.
Alexandria Real Estate’s portfolio of real estate holdings focused on the biopharmaceutical industry has not performed as well as investors would have liked. In 2026, non-cash impairment of property values caused the real estate investment trust to report a net loss of $1.4 billion. Funds from operations, a proxy for earnings used to evaluate REITs, came in at $1.5 billion, but that was 5.8% lower than the company reported in 2024.
Alexandria Real Estate reported a 90.9% occupancy rate at the end of 2025, which it expects to decline slightly. Management is guiding investors to an occupancy rate of between 87.7% and 89.3% by the end of 2026.
